Privacy policy
Prepared by: Research Desk. Sources are linked for verification.
This policy explains what data CognitivePepti handles and why.
Who runs this site
CognitivePepti is published by the CognitivePepti Research Desk. Contact: info@zvezdaff.com.
Data collected
The site has no accounts, comment forms or newsletter signups, and it does not ask visitors for personal information. It does not use advertising cookies and does not sell personal data.
The site is hosted on Framer. Like any web host, Framer processes the technical data needed to deliver pages, such as IP address, browser type and the pages requested, and it may produce aggregated visit statistics.
Links to other websites
Pages link to external sources such as PubMed and the FDA, and to Purita through paid links. A paid link carries a tracking code that Purita's website can record when the link is followed. Other websites apply their own privacy policies.
Messages sent to info@zvezdaff.com are used only to reply. Addresses are not added to any mailing list or shared.
Access and deletion
Requests to access, correct or delete personal data can be sent to info@zvezdaff.com.
Changes
Last updated: 21 October 2026.
More from CognitivePepti
Cognition-related peptides in research: Semax, Selank and DSIP compared
A side-by-side research reference on Semax, Selank and DSIP: where they came from, their sequences, the studies on record, proposed mechanisms and FDA status.
Selank: the tuftsin analogue and its research record
Selank is a synthetic heptapeptide built on the tuftsin sequence. This page summarises its origins, published preclinical work, regulatory record and remaining gaps.
DSIP (delta sleep-inducing peptide): fifty years of an unresolved peptide
DSIP was isolated from rabbit brain in 1977, yet its receptor and mechanism remain unresolved. A summary of the early studies, open questions and the 2026 FDA advisory agenda.